David Khidasheli serves as Executive at CALYPTE BIOMEDICAL CORP, where they oversee executive responsibilities. Since joining the company, David Khidasheli has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 16, 2008 involved exercising options for 2,000,000 shares valued at $100.0K.
David Khidasheli currently holds 34,000,000 shares of CALYPTE BIOMEDICAL CORP (CBMC.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Khidasheli has been a net neutral trader of CBMC.OB stock. They have purchased $0 and sold $0 worth of shares.
David Khidasheli's most recent insider trade was on Jun 16, 2008, when they sold 2,000,000 shares at $0.05 per share.
Get notified when new Form 4 filings are submitted
| 2,000,000 |
| $0.08 |
| Discretionary |